What is Neomorph?
Neomorph is a San Diego-based, venture-backed biotechnology company dedicated to advancing the science of targeted protein degradation. The company leverages its proprietary technology and a team of leading experts in protein degradation and molecular glues to pioneer novel drug discovery and clinical development. Neomorph's core mission is to address critical unmet needs in human health by creating transformative treatments for challenging diseases. Their approach is characterized by a patient-first, science-driven methodology, aiming to solve complex biological problems through innovative therapeutic strategies.
How much funding has Neomorph raised?
Neomorph has raised a total of $209M across 2 funding rounds:
Series A
$109M
Series B
$100M
Series A (2020): $109M with participation from Deerfield Communications Inc
Series B (2026): $100M led by Alexandria, Deerfield, Longwood Fund, and Regeneron Ventures
Key Investors in Neomorph
Deerfield Communications Inc
Deerfield Communications Inc is an investor in Neomorph's funding rounds. Further details on their specific investment focus are not provided.
Alexandria
Alexandria Real Estate Equities, Inc. is a real estate investment trust specializing in properties for the life sciences industry, supporting biotech and pharmaceutical entities.
Deerfield
Deerfield Management is an investment firm dedicated to advancing healthcare through investment and innovation, supporting companies across the healthcare ecosystem.
What's next for Neomorph?
With substantial enterprise-level backing and a recent strategic investment, Neomorph is well-positioned to accelerate its drug discovery and development pipeline. The company's focus on undruggable targets suggests a strategy aimed at high-impact therapeutic areas. Future endeavors will likely involve advancing preclinical candidates into clinical trials and potentially forging strategic partnerships to expand the reach of its innovative protein degradation platform. Continued investment in research and development will be crucial for Neomorph to solidify its leadership in the competitive biotechnology landscape.
See full Neomorph company page
